文献速递免疫规划传染病防控与疫情报告妇幼与学校卫生

疫苗与感染诱导的肺炎球菌和登革病毒NS1抗体经胎盘转移差异及母婴早期暴露负担

Vaccine- and infection-induced pneumococcal and DENV-NS1 antibodies reveal differential transplacental transfer and maternal-infant early exposure burden.
PubMed 文献 · Vaccine · 2026-09-14

在哥伦比亚南部登革热高度流行区,140名低风险孕妇在孕晚期随机接种PPSV23或Hib结合疫苗,纵向检测母体、脐带和婴儿的肺炎球菌23F特异性IgG及登革病毒NS1特异性IgG、IgM、IgA。结果显示疫苗与感染诱导抗体经胎盘转移及出生后持久性存在抗原和同种型差异,婴儿6月龄内出现NS1-IgA提示早期登革病毒感染。

要点

  • PPSV23提高母体抗Pn23F IgG,自然感染抗NS1 IgG保持稳定。
  • 抗NS1 IgG母胎水平强相关,抗Pn23F IgG无此强相关。
  • 婴儿抗NS1 IgG阳性率从出生99%降至6月龄74%。

核心结论

  • 疫苗与感染诱导抗体经胎盘转移和出生后持久性存在抗原及同种型差异,母婴早期暴露负担高。
  • 婴儿NS1-IgA出现证明出生后活跃登革传播,支持其作为早期暴露敏感标志物。

研究设计与样本

  • 哥伦比亚南部登革热高度流行区纵向队列,140名低风险孕妇孕晚期随机接种PPSV23或Hib结合疫苗。
  • ELISA检测母体、脐带和婴儿出生、3、6月龄时Pn23F特异性IgG及NS1特异性IgG、IgM、IgA,并检测循环NS1。
  • 临床随访至6月龄。

主要发现

  • PPSV23增加母体抗Pn23F IgG,自然感染抗NS1 IgG稳定。
  • 脐带血可检出抗Pn23F和抗NS1 IgG,抗NS1 IgG母胎水平强相关,抗Pn23F IgG无强相关。
  • 婴儿抗NS1 IgG阳性率从出生99%降至6月龄74%,PPSV23接种母亲婴儿抗Pn23F IgG水平稳定。
  • 尽管母体抗NS1 IgG血清阳性率99.1%,6月龄内13.1%婴儿出现抗NS1 IgM或IgA,无NS1抗原血症或临床登革表现。

关键数值与推荐

  • 婴儿抗NS1 IgG血清阳性率:出生99%,6月龄74%。
  • 母体抗NS1 IgG血清阳性率99.1%;6月龄内13.1%婴儿出现抗NS1 IgM或IgA。

临床怎么用

  • 孕晚期PPSV23可提高母体抗肺炎球菌IgG,但经胎盘转移与自然感染抗体不同。
  • 在高流行区可用NS1-IgA监测婴儿早期登革暴露。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnant women and their infants are vulnerable to severe infections with S. pneumoniae and dengue virus (DENV), for which early protection depends on maternally derived antibodies. Infection- and vaccine-induced responses may differ in quality and transfer, with implications for maternal immunization strategies. We evaluated isotype-specific antibody responses to pneumococcal vaccination and natural DENV infection in pregnant women and their infants and quantified early postnatal DENV exposure. METHODS: In a longitudinal cohort in southern Colombia, a DENV-hyperendemic region, 140 low-risk pregnant women received either PPSV23 or Hib conjugate vaccine randomly in the third trimester. Circulating pneumococcal serotype 23F (Pn23F)-specific IgG and DENV NS1-specific IgG, IgM, and IgA were measured by ELISA in maternal, cord, and infant at delivery, 3, and 6 months; circulating NS1 was used to detect active DENV infection. Postnatal clinical follow-up was performed until 6 months of age. RESULTS: PPSV23 increased maternal anti-Pn23F IgG, whereas anti-NS1 IgG from natural infection remained stable. Anti-Pn23F and anti-NS1 IgG were detectable in cord blood, but maternal-cord levels were strongly correlated for anti-NS1 IgG and not for anti-Pn23F IgG. Infant anti-NS1 IgG seropositivity declined from 99% at birth to 74% at 6 months, while anti-Pn23F IgG levels in infants of PPSV23-vaccinated mothers remained stable. Despite 99.1% maternal anti-NS1 IgG seroprevalence, 13.1% of infants developed anti-NS1 IgM or anti-NS1 IgA by 6 months, indicating early DENV infection without NS1 antigenemia or clinically apparent dengue. CONCLUSION: Vaccine- and infection-induced antibodies showed antigen- and isotype-specific differences in transplacental transfer and postnatal persistence, revealing a high burden in the maternal and early infant populations. The emergence of NS1-IgA in infants demonstrates active postnatal DENV transmission and supports NS1-IgA as a sensitive marker for early infant exposure and serosurveillance in hyperendemic settings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Polanía-Espinosa D, Salgado D, Vega R, et al. Vaccine- and infection-induced pneumococcal and DENV-NS1 antibodies reveal differential transplacental transfer and maternal-infant early exposure burden. Vaccine. 2026. PMID: 42735604. doi:10.1016/j.vaccine.2026.129138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。